CN105981024B - 用于提供关于药物使用的个性化推荐的基于网络的计算机辅助方法和系统及计算机可读介质 - Google Patents

用于提供关于药物使用的个性化推荐的基于网络的计算机辅助方法和系统及计算机可读介质 Download PDF

Info

Publication number
CN105981024B
CN105981024B CN201480075387.5A CN201480075387A CN105981024B CN 105981024 B CN105981024 B CN 105981024B CN 201480075387 A CN201480075387 A CN 201480075387A CN 105981024 B CN105981024 B CN 105981024B
Authority
CN
China
Prior art keywords
information
drug
personalized recommendation
patient
user
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480075387.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN105981024A (zh
Inventor
J·普拉瑟瓦尔·加尔恰
D·雷东多·阿马多
M·图松·塞加拉
S·比尔切斯·赛斯
J·埃斯帕达勒·马索
A·萨拉韦特·拉罗萨
M·A·博纳切拉·谢拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Precision Molecular Solutions Co ltd
Original Assignee
Bio Co ltd AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Co ltd AB filed Critical Bio Co ltd AB
Publication of CN105981024A publication Critical patent/CN105981024A/zh
Application granted granted Critical
Publication of CN105981024B publication Critical patent/CN105981024B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/10—Analysis or design of chemical reactions, syntheses or processes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/90—Programming languages; Computing architectures; Database systems; Data warehousing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L41/00—Arrangements for maintenance, administration or management of data switching networks, e.g. of packet switching networks
    • H04L41/22—Arrangements for maintenance, administration or management of data switching networks, e.g. of packet switching networks comprising specially adapted graphical user interfaces [GUI]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L67/00—Network arrangements or protocols for supporting network services or applications
    • H04L67/01—Protocols
    • H04L67/02—Protocols based on web technology, e.g. hypertext transfer protocol [HTTP]

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Computing Systems (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Human Computer Interaction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Software Systems (AREA)
  • Databases & Information Systems (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
CN201480075387.5A 2013-12-12 2014-12-10 用于提供关于药物使用的个性化推荐的基于网络的计算机辅助方法和系统及计算机可读介质 Active CN105981024B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361915077P 2013-12-12 2013-12-12
US61/915,077 2013-12-12
PCT/IB2014/002715 WO2015087140A1 (en) 2013-12-12 2014-12-10 Web-based computer-aided method and system for providing personalized recommendations about drug use, and a computer-readable medium

Publications (2)

Publication Number Publication Date
CN105981024A CN105981024A (zh) 2016-09-28
CN105981024B true CN105981024B (zh) 2019-03-26

Family

ID=52434853

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480075387.5A Active CN105981024B (zh) 2013-12-12 2014-12-10 用于提供关于药物使用的个性化推荐的基于网络的计算机辅助方法和系统及计算机可读介质

Country Status (7)

Country Link
US (1) US10943672B2 (https=)
EP (1) EP3080738A1 (https=)
JP (1) JP6596424B2 (https=)
KR (1) KR102362422B1 (https=)
CN (1) CN105981024B (https=)
CA (1) CA2932983C (https=)
WO (1) WO2015087140A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3239869A1 (en) 2016-04-29 2017-11-01 Fujitsu Limited A system and method to produce and validate weighted relations between drug and adverse drug reactions
CN106326652A (zh) * 2016-08-23 2017-01-11 北京博奥医学检验所有限公司 一种肿瘤智能用药指导系统
US10621558B2 (en) 2016-10-07 2020-04-14 Bank Of America Corporation System for automatically establishing an operative communication channel to transmit instructions for canceling duplicate interactions with third party systems
US10510088B2 (en) * 2016-10-07 2019-12-17 Bank Of America Corporation Leveraging an artificial intelligence engine to generate customer-specific user experiences based on real-time analysis of customer responses to recommendations
US10476974B2 (en) 2016-10-07 2019-11-12 Bank Of America Corporation System for automatically establishing operative communication channel with third party computing systems for subscription regulation
WO2018140156A1 (en) * 2017-01-27 2018-08-02 Orig3N, Inc. Systems and methods for determining and presenting purchase recommendations based on personal genetic profiles
CN108629149B (zh) * 2017-03-21 2023-04-07 达易特基因科技股份有限公司 基因检测平台方法
CN120636518A (zh) * 2017-05-12 2025-09-12 密歇根大学董事会 个体和队列药理学表型预测平台
CN107273710A (zh) * 2017-08-22 2017-10-20 北京岙特杰诺生物科技有限公司 一种建立药物代谢酶基因与药物代谢的关系模型的方法
JP7320345B2 (ja) * 2017-10-27 2023-08-03 シスメックス株式会社 遺伝子解析方法、遺伝子解析装置、遺伝子解析システム、プログラム、および記録媒体
WO2019083024A1 (ja) * 2017-10-27 2019-05-02 シスメックス株式会社 遺伝子解析方法、遺伝子解析装置、管理サーバ、遺伝子解析システム、プログラム、および記録媒体
CA3080468A1 (en) 2017-10-30 2019-05-09 Endocanna Health, Inc. Cannabinoid formulations
CN108682458A (zh) * 2018-05-08 2018-10-19 北京岙特杰诺生物科技有限公司 用药管理方法、装置及电子设备
WO2020005321A1 (en) * 2018-06-28 2020-01-02 Powell Roberta D Patient-facing digital platform for health literacy and numeracy
US20200004928A1 (en) * 2018-06-29 2020-01-02 Roche Sequencing Solutions, Inc. Computing device with improved user interface for interpreting and visualizing data
IT201800007351A1 (it) * 2018-07-19 2020-01-19 Sistema e metodo attuato mediante calcolatore per visualizzazione dinamica d’interazione tra farmaci
WO2020091375A2 (ko) * 2018-10-29 2020-05-07 고려대학교 산학협력단 항우울제 추천 방법 및 시스템
US20220310208A1 (en) * 2019-06-13 2022-09-29 Roche Sequencing Solutions, Inc. Systems and methods with improved user interface for interpreting and visualizing longitudinal
EP3822974A1 (en) * 2019-11-15 2021-05-19 Stalicla S.A. Computational platform to identify therapeutic treatments for neurodevelopmental conditions
KR20210096402A (ko) * 2020-01-28 2021-08-05 (주)인테그로메디랩 증례 데이터 기반 천연물 추천 장치 및 방법
KR20210103338A (ko) 2020-02-13 2021-08-23 윤명철 유전자 정보를 이용하는 상품 추천 시스템 및 방법
US11238967B1 (en) * 2021-02-24 2022-02-01 Flatiron Health, Inc. Systems and methods for generating dynamic graphical user interfaces for dose recalculations and adjustments
KR102918109B1 (ko) * 2021-06-07 2026-01-28 (주) 애니펜 콘텐츠를 제공하기 위한 방법, 시스템 및 비일시성의 컴퓨터 판독 가능 기록 매체
WO2024053860A1 (ko) 2022-09-05 2024-03-14 주식회사 지놈인사이트테크놀로지 유전 정보 분석 결과 제공 방법 및 시스템
KR102834065B1 (ko) * 2022-09-22 2025-07-16 서울대학교산학협력단 약동학적 변화량 예측 장치 및 방법
CN120641989A (zh) * 2022-10-06 2025-09-12 蓝色基因实验室有限责任公司 药物相互作用分析的系统和方法
KR102659367B1 (ko) * 2023-08-04 2024-04-22 웰트 주식회사 멀티소스 데이터 분석을 기반으로 한 맞춤형 디지털 치료제 생성 방법 및 이러한 방법을 수행하는 장치
CN118737369B (zh) * 2024-06-07 2025-07-01 武汉海云健康科技股份有限公司 一种基于多任务学习的个性化用药推荐方法、设备及存储介质
CN118737311B (zh) * 2024-09-03 2024-11-22 艾伟拓(江苏)医药科技有限公司 一种二甲氨丁酸二亚油甲酯配伍方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429544A (zh) * 2008-12-18 2009-05-13 黄行许 利用rna干扰文库筛选肿瘤化疗药物敏感基因的方法
US8099298B2 (en) * 2007-02-14 2012-01-17 Genelex, Inc Genetic data analysis and database tools

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060034508A1 (en) * 2004-06-07 2006-02-16 Zhou Xiang S Computer system and method for medical assistance with imaging and genetics information fusion
US7504227B2 (en) * 2004-10-20 2009-03-17 University Of Washington Drug targets for the treatment of neurodegenerative disorders
EP3703058A1 (en) * 2005-11-29 2020-09-02 Children's Hospital Medical Center A method of selecting a medication for a patient
CN102067142A (zh) * 2008-02-26 2011-05-18 普渡研究基金会 用于患者基因分型的方法
KR20110074527A (ko) * 2008-09-12 2011-06-30 네이비제닉스 인크. 복수의 환경 및 유전 위험 인자를 통합하기 위한 방법 및 시스템
US20110082867A1 (en) * 2009-10-06 2011-04-07 NeX Step, Inc. System, method, and computer program product for analyzing drug interactions
US9773091B2 (en) 2011-10-31 2017-09-26 The Scripps Research Institute Systems and methods for genomic annotation and distributed variant interpretation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8099298B2 (en) * 2007-02-14 2012-01-17 Genelex, Inc Genetic data analysis and database tools
CN101429544A (zh) * 2008-12-18 2009-05-13 黄行许 利用rna干扰文库筛选肿瘤化疗药物敏感基因的方法

Also Published As

Publication number Publication date
CA2932983A1 (en) 2015-06-18
CA2932983C (en) 2021-06-08
JP6596424B2 (ja) 2019-10-23
US10943672B2 (en) 2021-03-09
US20160314251A1 (en) 2016-10-27
EP3080738A1 (en) 2016-10-19
WO2015087140A1 (en) 2015-06-18
KR20160099618A (ko) 2016-08-22
CN105981024A (zh) 2016-09-28
JP2017503258A (ja) 2017-01-26
KR102362422B1 (ko) 2022-02-11

Similar Documents

Publication Publication Date Title
CN105981024B (zh) 用于提供关于药物使用的个性化推荐的基于网络的计算机辅助方法和系统及计算机可读介质
Jenkins et al. Efficacy of supervised maintenance exercise following pulmonary rehabilitation on health care use: a systematic review and meta-analysis
Brandes et al. Can the common-sense model predict adherence in chronically ill patients? A meta-analysis
Shore et al. Site-level variation in and practices associated with dabigatran adherence
Zaitsoff et al. The role of the therapeutic alliance in eating disorder treatment outcomes: a systematic review
Whalley Buono et al. Coming full circle in the measurement of medication adherence: opportunities and implications for health care
Pinem et al. Designing a health referral mobile application for high-mobility end users in Indonesia
US10424400B2 (en) Clinical trial investigators performance assessment
Clay et al. Economic burden for Alzheimer’s disease in China from 2010 to 2050: a modelling study
Curtin et al. Assessing the benefit: risk ratio of a drug-randomized and naturalistic evidence
US20210256545A1 (en) Summarizing and presenting recommendations of impact factors from unstructured survey response data
JP2017503258A5 (https=)
Woosley et al. Assessing cardiovascular drug safety for clinical decision-making
Rassouli et al. Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk
Senapati et al. Enriching healthcare service quality by leveraging service experiences in Indian private hospitals: application of fuzzy-AHP approach
Bakhshayesh et al. Cost-utility analysis of home-based cardiac rehabilitation as compared to usual post-discharge care: systematic review and meta-analysis of randomized controlled trials
Zheng et al. Genotype-guided antiplatelet therapy compared with conventional therapy for patients with acute coronary syndromes: a systematic review and meta-analysis
McCoy et al. Pushing the international health research agenda towards equity and effectiveness
Knights et al. Evaluating digital medicine ingestion data from seriously mentally ill patients with a Bayesian Hybrid Model
Rothenbacher et al. New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis
An et al. The need for double-sampling designs in survival studies: an application to monitor PEPFAR
Sugiharto et al. Comparative Systematic Review of Telehealth Delivery Models, Intervention Content, and Outcomes in Heart Failure Care
Huang et al. Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States
Barzdins et al. Towards evidence-based management: A nationwide administrative data-based audit of acute myocardial infarction in Latvia
Erstad Value-based medicine: dollars and sense

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20240304

Address after: south carolina

Patentee after: Precision Molecular Solutions Co.,Ltd.

Country or region after: U.S.A.

Address before: Spain Zelda Niaoladeer Vallis

Patentee before: AB Bio Co.,Ltd.

Country or region before: Spain

TR01 Transfer of patent right